Skip to main content

dexmedetomidine (Dexdor®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 17. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name dexmedetomidine (Dexdor®)
Formulation 100 micrograms/ml concentrate for solution for infusion
Reference number 3949
Indication

Sedation of non-intubated adult patients prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation

Company Orion Pharma (UK) Ltd
BNF chapter Anaesthesia
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 08/11/2018
Follow AWTTC: